Escher, T.E.; Dandawate, P.; Sayed, A.; Hagan, C.R.; Anant, S.; Lewis-Wambi, J.
Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers 2021, 13, 5130.
https://doi.org/10.3390/cancers13205130
AMA Style
Escher TE, Dandawate P, Sayed A, Hagan CR, Anant S, Lewis-Wambi J.
Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers. 2021; 13(20):5130.
https://doi.org/10.3390/cancers13205130
Chicago/Turabian Style
Escher, Taylor E., Prasad Dandawate, Afreen Sayed, Christy R. Hagan, Shrikant Anant, and Joan Lewis-Wambi.
2021. "Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer" Cancers 13, no. 20: 5130.
https://doi.org/10.3390/cancers13205130
APA Style
Escher, T. E., Dandawate, P., Sayed, A., Hagan, C. R., Anant, S., & Lewis-Wambi, J.
(2021). Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers, 13(20), 5130.
https://doi.org/10.3390/cancers13205130